News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,354 Results
Type
Article (64425)
Company Profile (205)
Press Release (601724)
Section
Business (180919)
Career Advice (2789)
Deals (33723)
Drug Delivery (100)
Drug Development (79524)
Employer Resources (150)
FDA (15476)
Job Trends (14717)
News (317574)
Policy (30978)
Tag
Academia (2920)
Alliances (45387)
Alzheimer's disease (1275)
Approvals (15443)
Artificial intelligence (190)
Bankruptcy (290)
Best Places to Work (11666)
Biotechnology (150)
Breast cancer (213)
Cancer (1592)
Cardiovascular disease (123)
Career advice (2360)
CAR-T (120)
Cell therapy (337)
Clinical research (63736)
Collaboration (601)
Compensation (228)
COVID-19 (2635)
C-suite (154)
Data (1513)
Diabetes (198)
Diagnostics (6207)
Earnings (62548)
Employer resources (133)
Events (99246)
Executive appointments (544)
FDA (16305)
Funding (554)
Gene therapy (235)
GLP-1 (664)
Government (4604)
Healthcare (19025)
Infectious disease (2730)
Inflammatory bowel disease (122)
Interviews (532)
IPO (15505)
Job creations (3528)
Job search strategy (1990)
Layoffs (474)
Legal (6945)
Lung cancer (231)
Manufacturing (219)
Medical device (12761)
Medtech (12766)
Mergers & acquisitions (18574)
Metabolic disorders (516)
Neuroscience (1660)
NextGen: Class of 2025 (6681)
Non-profit (4581)
Northern California (1787)
Obesity (292)
Opinion (227)
Patents (135)
People (59711)
Phase I (19879)
Phase II (27949)
Phase III (20792)
Pipeline (622)
Postmarket research (2712)
Preclinical (8494)
Radiopharmaceuticals (255)
Rare diseases (304)
Real estate (6159)
Regulatory (21076)
Research institute (2476)
Resumes & cover letters (414)
Southern California (1589)
Startups (3470)
United States (16529)
Vaccines (600)
Weight loss (203)
Date
Last 7 days (606)
Last 30 days (2574)
Last 365 days (33511)
2025 (2648)
2024 (34019)
2023 (38269)
2022 (48852)
2021 (53690)
2020 (52710)
2019 (46601)
2018 (35456)
2017 (32058)
2016 (31523)
2015 (36912)
2014 (29742)
2013 (26350)
2012 (27632)
2011 (27809)
2010 (26095)
Location
Africa (921)
Arizona (155)
Asia (40598)
Australia (7037)
California (4143)
Canada (1504)
China (369)
Colorado (190)
Connecticut (216)
Europe (91726)
Florida (618)
Georgia (154)
Illinois (466)
Indiana (248)
Maryland (681)
Massachusetts (3199)
Michigan (191)
Minnesota (275)
New Jersey (1223)
New York (1214)
North Carolina (832)
Northern California (1787)
Ohio (152)
Pennsylvania (955)
South America (1230)
Southern California (1589)
Texas (626)
Utah (128)
Washington State (438)
666,354 Results for "shanghai jiao tong university school of medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Business
Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board
Phanes Therapeutics, Inc. announced that Professor Shun Lu, an internationally renowned oncologist and professor at Shanghai Jiao Tong University Chest Hospital, has joined the Company’s Clinical Advisory Board.
September 14, 2023
·
3 min read
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres’s Lab at the University of Colorado School of Medicine.
March 26, 2024
·
4 min read
Press Releases
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
October 16, 2024
·
5 min read
Business
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine),
March 21, 2024
·
2 min read
Nature Cancer Publishes the Collaborative Study Results by Transcenta and Shanghai Jiao Tong University Scientists
Transcenta Holding Limited announces that Nature Cancer, an international authoritative journal in oncology field, publishes the results of preclinical studies of Transcenta’s first-in-class Gremlin1 targeting antibody in the treatment of castration resistant prostate cancer.
May 30, 2022
·
6 min read
Xinhua Silk Road: Pien Tze Huang, Beijing Tong Ren Tang agree to boost bilateral cooperation, promote high-quality development of TCM
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. signed a cooperation agreement with Beijing Tong Ren Tang Group during the First Conference of Partners of Tong Ren Tang, which was held in Beijing from January 17 to 19.
February 1, 2024
·
1 min read
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen’s Lab at Emory University School of Medicine.
March 28, 2024
·
4 min read
Drug Development
RS BioTherapeutics Announces Research Collaboration with University of Colorado School of Medicine
July 9, 2024
·
4 min read
Business
Kaiser Permanente Bernard J. Tyson School of Medicine appoints Dr. John L. Dalrymple as new Dean and CEO
The Board of Directors of the Kaiser Permanente Bernard J. Tyson School of Medicine announced the appointment of physician, educator, and women’s health expert John L. Dalrymple, MD, as the school’s new Dean and CEO after an extensive national search.
April 16, 2024
·
4 min read
1 of 66,636
Next
